Psychological distress among early medical residents: A 2-year longitudinal cohort study over seven years in Japan.

Watanabe S, Uemura T, Iwata Y, Yagasaki H, Itakura J, Suzuki T.

Comprehensive Psychiatry   2023年

Predictors of response to pharmacotherapy in children and adolescents with psychiatric disorders: A combined post hoc analysis of four clinical trial data. 査読

Tsujii T, Sakurai H, Takeuchi H, Suzuki T, Mimura M, Uchida H.

Neuropsychopharmacol Rep.   2022年11月

A 93-year-old patient with major depressive disorder successfully treated with electroconvulsive therapy: A case report and review of the literature: Electroconvulsive therapy in a 93 y.o. patient. 査読

Tada Teruo, Yasuda Kazuyuki, Watanabe Shintaro, Ishibashi Akifumi, Watanabe Koichiro, Suzuki Takefumi.

Psychiatry Research Case Reports.   2022年6月

Electroconvulsive Therapy in a Patient With Depression on Hemodialysis: A Review of the Literature. 査読

Watanabe S, Yasuda K, Tada T, Ishibashi A, Suzuki T.

J ECT.   2022年5月

Dopaminergic dysfunction and excitatory/inhibitory imbalance in treatment-resistant schizophrenia and novel neuromodulatory treatment. 査読

Wada M, Noda Y, Iwata Y, Tsugawa S, Yoshida K, Tani H, Hirano Y, Koike S, Sasabayashi D, Katayama H, Plitman E, Ohi K, Ueno F, Caravaggio F, Koizumi T, Gerretsen P, Suzuki T, Uchida H, Müller DJ, Mimura M, Remington G, Grace AA, Graff-Guerrero A, Nakajima S.

Mol Psychiatry   2022年4月

Catheter-related bloodstream infection in patients With severe anorexia nervosa. 査読

Hirata T, Yasuda K, Iwata Y, Uemura T, Aruga Y, Shioe R, Uchinuma N, Tamaoki T, Suzuki T.

PERSPECTIVES IN PSYCHIATRIC CARE   2022年2月( ISSN：0031-5990 )

MAP Bayesian modeling combining striatal dopamine receptor occupancy and plasma concentrations to optimize antipsychotic dose regimens in individual patients. 査読

Ismail M, Straubinger T, Uchida H, Graff-Guerrero A, Nakajima S, Suzuki T, Caravaggio F, Gerretsen P, Mamo D, Mulsant BH, Pollock BG, Bies R.

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY   2022年2月( ISSN：0306-5251 )

Decision tree classification of cognitive functions with D2 receptor occupancy and illness severity in late-life schizophrenia. 査読

Kusudo K, Ochi R, Nakajima S, Suzuki T, Mamo D, Caravaggio F, Mar W, Gerretsen P, Mimura M, Pollock BG, Mulsant BH, Graff-Guerrero A, Rajji TK, Uchida H.

SCHIZOPHRENIA RESEARCH   2022年2月( ISSN：0920-9964 )

Cancellation of outpatient appointments in patients with attention-deficit/hyperactivity disorder. 査読

Nomura K, Tarumi R, Yoshida K, Sado M, Suzuki T, Mimura M, Uchida H.

PLoS One   2021年11月( ISSN：1932-6203 )

Comorbid Psychiatric Disorders in Patients Hospitalized for Pulmonary Embolism and Acute Myocardial Infarction: A Japanese Nationwide Database Study. 査読

Takahashi K, Uchida H, Suzuki T, Mimura M, Ishida T.

JOURNAL OF CLINICAL PSYCHIATRY   2021年11月( ISSN：0160-6689 )

Clinical Characteristics of Patients with Schizophrenia Maintained without Antipsychotics: A Cross-sectional Survey of a Case Series. 査読

Tani H, Tomita M, Suzuki T, Mimura M, Uchida H.

Clinical Psychopharmacology and Neuroscience   2021年11月( ISSN：1738-1088 )

Antipsychotic treatment strategies for acute phase and treatment resistance in schizophrenia: A systematic review of the guidelines and algorithms. 査読

Shimomura Y, Kikuchi Y, Suzuki T, Uchida H, Mimura M, Takeuchi H.

SCHIZOPHRENIA RESEARCH   2021年9月( ISSN：0920-9964 )

Development of a risk stratification scoring system for deep vein thrombosis upon psychiatric admission. 査読

Ishida T, Shibahashi K, Sugai S, Abe D, Hamabe Y, Kashiyama T, Mimura M, Suzuki T, Uchida H.

JOURNAL OF PSYCHOSOMATIC RESEARCH   2021年5月( ISSN：0022-3999 )

Prescription patterns in patients with schizophrenia who discontinued long-acting injectable antipsychotics: a chart-review. 査読

Asano K, Suzuki T, Mimura M, Uchida H.

PSYCHIATRY AND CLINICAL NEUROSCIENCES   2021年3月( ISSN：1323-1316 )

Successful Introduction of Paliperidone Palmitate for Pregnant Woman With Schizophrenia: Case Presentation and Literature Review. 査読

Iwata Y, Aruga Y, Ohtsuki M, Inoue M, Yasuda K, Hirata T, Uemura T, Suzuki T.

JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY   2021年3月( ISSN：0271-0749 )

Pre-existing psychiatric disorder is related to lower mortality from road traffic accident: A Japanese nationwide retrospective cohort study. 査読

Ishida T, Kuwahara Y, Shibahashi K, Okura Y, Sugiyama K, Yoshimura K, Hamabe Y, Mimura M, Suzuki T, Uchida H.

INJURY-INTERNATIONAL JOURNAL OF THE CARE OF THE INJURED   2021年2月( ISSN：0020-1383 )

Single Versus Multiple Daily Dosing Regimens of Psychotropic Drugs for Psychiatric Disorders: A Systematic Review and Meta-Analysis. 査読

Kikuchi Y, Shimomura Y, Suzuki T, Uchida H, Mimura M, Takeuchi H.

JOURNAL OF CLINICAL PSYCHIATRY   2021年2月( ISSN：0160-6689 )

Pharmacological Treatment of Schizophrenia: Japanese Expert Consensus. 査読

Sakurai H, Yasui-Furukori N, Suzuki T, Uchida H, Baba H, Watanabe K, Inada K, Kikuchi YS, Kikuchi T, Katsuki A, Kishida I, Kato M.

PHARMACOPSYCHIATRY   2021年1月( ISSN：0176-3679 )

Flumazenil for Successful Seizure Induction With Electroconvulsive Therapy: Case Report and Literature Review. 査読

Uchinuma N, Yasuda K, Iwata Y, Hirata T, Uemura T, Tamaoki T, Suzuki T.

CLINICAL NEUROPHARMACOLOGY   2020年( ISSN：0362-5664 )

How common is pulmonary embolism compared to acute myocardial infarction among patients with severe mental illnesses? 査読

Ishida T, Takahashi K, Sugiyama K, Hamabe Y, Mimura M, Suzuki T, Uchida H.

PSYCHIATRY AND CLINICAL NEUROSCIENCES   2020年( ISSN：1323-1316 )

Pharmacological management of depression: Japanese expert consensus. 査読

Sakurai H, Uchida H, Kato M, Suzuki T, Baba H, Watanabe K, Inada K, Kikuchi T, Katsuki A, Kishida I, Sugawara Kikuchi Y, Yasui-Furukori N; Medical Education Panel of the Japanese Society of Clinical Neuropsychopharmacology.

JOURNAL OF AFFECTIVE DISORDERS   2020年( ISSN：0165-0327 )

Life-Threatening Serotonin Syndrome Precipitated by Discontinuation of Serotonin-Dopamine Antagonist in the Presence of Serotonergic Agents: A Case Report. 査読

Ishida T, Uchida H, Kaneko S, Sugiyama K, Hamabe Y, Mimura M, Suzuki T.

CLINICAL NEUROPHARMACOLOGY   2020年( ISSN：0362-5664 )

Drug Attitude, Insight, and Patient's Knowledge About Prescribed Antipsychotics in Schizophrenia: A Cross-Sectional Survey. 査読

Nagai N, Tani H, Yoshida K, Gerretsen P, Suzuki T, Ikai-Tani S, Mimura M, Uchida H.

Neuropsychiatric Disease and Treatment   2020年

Factors Associated with Non-Remission in Bipolar Disorder: The Multicenter Treatment Survey for Bipolar Disorder in Psychiatric Outpatient Clinics (MUSUBI). 査読

Tsuboi T, Suzuki T, Azekawa T, Adachi N, Ueda H, Edagawa K, Katsumoto E, Kubota Y, Goto E, Hongo S, Watanabe Y, Kato M, Yasui-Furukori N, Yoshimura R, Nakagawa A, Kikuchi T, Watanabe K.

Neuropsychiatric Disease and Treatment   2020年

Electroconvulsive therapy in patients with cerebral aneurysms taking an anticoagulant or antiplatelet-report on three cases and review of the literature. 査読

Hirata T, Yasuda K, Uemura T, Ueda T, Aruga Y, Shioe R, Tamaoki T, Suzuki T.

PSYCHIATRY RESEARCH   2020年( ISSN：0165-1781 )

Gap between patients with schizophrenia and their psychiatrists on the needs to psychopharmacological treatment: A cross-sectional study. 査読

Takahashi K, Yamazawa R, Suzuki T, Mimura M, Uchida H.

Neuropsychopharmacol Rep.   2020年

Pharmacological Management of Bipolar Disorder: Japanese Expert Consensus. 査読

Sakurai H, Kato M, Yasui-Furukori N, Suzuki T, Baba H, Watanabe K, Inada K, Kishida I, Sugawara Kikuchi Y, Kikuchi T, Katsuki A, Uchida H; Medical Education Panel of the Japanese Society of Clinical Neuropsychopharmacology.

BIPOLAR DISORDERS   2020年( ISSN：1398-5647 )

Dissociation in Pharmacokinetic Attenuation Between Central Dopamine D2 Receptor Occupancy and Peripheral Blood Concentration of Antipsychotics: A Systematic Review. 査読

Kurose S, Mimura Y, Uchida H, Takahata K, Kim E, Suzuki T, Mimura M, Takeuchi H.

JOURNAL OF CLINICAL PSYCHIATRY   2020年( ISSN：0160-6689 )

Lower mortality from suicidal trauma among patients with a psychiatric diagnosis upon admission: Nationwide japanese retrospective cohort study. 査読

Ishida T, Kuwahara Y, Shibahashi K, Okura Y, Sugiyama K, Hamabe Y, Mimura M, Suzuki T, Uchida H.

PSYCHIATRY RESEARCH   2020年( ISSN：0165-1781 )

Factors Associated With Delirium Following Electroconvulsive Therapy: A Systematic Review

Tsujii T, Uchida T, Suzuki T, Mimura M, Hirano J, Uchida H.

JOURNAL OF ECT   2019年12月( ISSN：1095-0680 )

Antipsychotic treatment in the maintenance phase of schizophrenia: An updated systematic review of the guidelines and algorithms. 査読

Shimomura Y, Kikuchi Y, Suzuki T, Uchida H, Mimura M, Takeuchi H.

SCHIZOPHRENIA RESEARCH   2019年( ISSN：0920-9964 )

Concomitant use of alcohol and benzodiazepine hypnotics in psychiatric outpatients: a cross-sectional survey. 査読

Uchida T, Hirano J, Sakurai H, Suzuki T, Mimura M, Uchida H.

INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY   2019年( ISSN：0268-1315 )

Alteration in AMPA receptor subunit expression and receptor binding among patients with addictive disorders: A systematic review of human postmortem studies. 査読

Ueno F, Suzuki T, Nakajima S, Matsushita S, Mimura M, Miyazaki T, Takahashi T, Uchida H.

Neuropsychopharmacol Rep.   2019年

Model-Guided Antipsychotic Dose Reduction in Schizophrenia: A Pilot, Single-Blind Randomized Controlled Trial. 査読

Ozawa C, Bies RR, Pillai N, Suzuki T, Mimura M, Uchida H.

JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY   2019年( ISSN：0271-0749 )

Circadian patterns of hallucinatory experiences in patients with schizophrenia: Potentials for chrono-pharmacology. 査読

Koizumi T, Suzuki T, Pillai NS, Bies RR, Takeuchi H, Yoshimura K, Mimura M, Uchida H.

JOURNAL OF PSYCHIATRIC RESEARCH   2019年( ISSN：0022-3956 )

Effectiveness and safety of long-term benzodiazepine use in anxiety disorders: a systematic review and meta-analysis. 査読

Shinfuku M, Kishimoto T, Uchida H, Suzuki T, Mimura M, Kikuchi T.

INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY   2019年( ISSN：0268-1315 )

Antipsychotic serious adverse events in context. 査読

Suzuki T.

Lancet Psychiatry   2019年( ISSN：2215-0374 )

Transvestism Recognized in Ehlers-Danlos Syndrome: Report of Two Cases. 査読

Ishiguro H, Honobe N, Suzuki T, Tamai M, Nakane T.

Case Rep Psychiatry.   2019年

Lower Proportion of Fatal Arrhythmia in Sudden Cardiac Arrest Among Patients With Severe Mental Illness Than Nonpsychiatric Patients. 査読

Ishida T, Sugiyama K, Tanabe T, Hamabe Y, Mimura M, Suzuki T, Uchida H.

PSYCHOSOMATICS   2019年( ISSN：0033-3182 )

Predicting relapse with residual symptoms in schizophrenia: A secondary analysis of the PROACTIVE trial. 査読

Saito Y, Sakurai H, Kane JM, Schooler NR, Suzuki T, Mimura M, Uchida H.

SCHIZOPHRENIA RESEARCH   2019年( ISSN：0920-9964 )

Factors Associated With Delirium Following Electroconvulsive Therapy: A Systematic Review.

Tsujii T, Uchida T, Suzuki T, Mimura M, Hirano J, Uchida H.

JOURNAL OF ECT   2019年( ISSN：1095-0680 )

Factors associated with successful antipsychotic dose reduction in schizophrenia: a systematic review of prospective clinical trials and meta-analysis of randomized controlled trials. 査読

Tani H, Takasu S, Uchida H, Suzuki T, Mimura M, Takeuchi H

NEUROPSYCHOPHARMACOLOGY   2019年( ISSN：0893-133X )

Etiologies of out-of-hospital cardiac arrest among psychiatric patients: a chart review. 査読

Ishida T, Miyazaki K, Yukawa T, Yamagishi T, Sugiyama K, Tanabe T, Hamabe Y, Mimura M, Suzuki T, Uchida H.

PSYCHIATRY AND CLINICAL NEUROSCIENCES   2018年( ISSN：1323-1316 )

Religiosity and psychological resilience in patients with schizophrenia and bipolar disorder: an international cross-sectional study. 査読

Mizuno Y, Hofer A, Frajo-Apor B, Wartelsteiner F, Kemmler G, Pardeller S, Suzuki T, Mimura M, Fleischhacker WW, Uchida H.

Acta Psychiatr Scand. 2017 Nov 15. doi: 10.1111/acps.12838. [Epub ahead of print]   2018年

Subtyping Schizophrenia by Social Functioning - a Pragmatic Proposal for Clinics and Research 査読

Suzuki T

Psychiatr Q. 2018 Jan 3. doi: 10.1007/s11126-017-9558-z. [Epub ahead of print]   2018年

A Possible Role of Takotsubo Cardiomyopathy in Ventricular Fibrillation During Delirium Tremens: A Case Report and Literature Review. 査読

Ishida T, Uchida H, Miyazaki K, Yukawa T, Sugiyama K, Hamabe Y, Mimura M, Suzuki T.

Psychosomatics. 2017 Nov 24. pii: S0033-3182(17)30228-1. doi: 10.1016/j.psym.2017.11.008. [Epub ahead of print]   2018年

Discrepancies Between Nomenclature and Indications of Psychotropics. 査読

Minami F, Zohar J, Suzuki T, Koizumi T, Mimura M, Yagi G, Uchida H.

PHARMACOPSYCHIATRY   2018年( ISSN：0176-3679 )

Kampo, A Japanese Traditional Medicinal System for Psychiatric Conditions: A Narrative Review. 査読

Tatsumi L, Suzuki T, Yamada K, Mimura M, Uchida H.

PHARMACOPSYCHIATRY   2018年( ISSN：0176-3679 )

Psychopharmacology in Japan: An Overview and Recent Topics. 査読

Yoshida K, Suzuki T, Uchida H.

JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY   2018年( ISSN：0271-0749 )

Placebo effects in adult and adolescent patients with schizophrenia: combined analysis of nine RCTs. 査読

Kubo K, Fleischhacker WW, Suzuki T, Yasui-Furukori N, Mimura M, Uchida H.

ACTA PSYCHIATRICA SCANDINAVICA   2018年( ISSN：0001-690X )

Clinical Characteristics of Patients With Schizophrenia Who Successfully Discontinued Antipsychotics: A Literature Review. 査読

Tani H, Suzuki T, Wolfgang Fleischhacker W, Tomita M, Mimura M, Uchida H.

JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY   2018年( ISSN：0271-0749 )

Mood stabilizers as an Achilles' heel for indication-based nomenclature and roles of Neuroscience-based Nomenclature. 査読

Kikuchi Y, Zohar J, Suzuki T, Mimura M, Yagi G, Uchida H.

PSYCHIATRY AND CLINICAL NEUROSCIENCES   2018年( ISSN：1323-1316 )

Electroconvulsive Therapy While Receiving Oral Anticoagulation for Deep Venous Thrombosis: Report on Eight Cases and a Review of the Literature. 査読

Hirata T, Yasuda K, Uemura T, Ohtsuki M, Kobayashi K, Ueda T, Aruga Y, Tamaoki T, Suzuki T.

PSYCHOSOMATICS   2018年( ISSN：0033-3182 )

Early Placebo Improvement Is a Marker for Subsequent Placebo Response in Long-Acting Injectable Antipsychotic Trials for Schizophrenia: Combined Analysis of 4 RCTs. 査読

Kumagai F, Suzuki T, Fleischhacker WW, Yasui-Furukori N, Mimura M, Uchida H.

JOURNAL OF CLINICAL PSYCHIATRY   2018年( ISSN：0160-6689 )

Mortality from sepsis among patients with schizophrenia and mood disorders in an intensive care unit: A chart review. 査読

Ishida T, Nakamura K, Miyazaki K, Yukawa T, Yamagishi T, Sugiyama K, Tanabe T, Hamabe Y, Mimura M, Suzuki T, Uchida H.

PSYCHIATRY RESEARCH   2018年( ISSN：0165-1781 )

Impact of subjective vs. objective remission status on subjective cognitive impairments in depression. 査読

Sawada K, Yoshida K, Ozawa C, Mizuno Y, Rubinstein EB, Suzuki T, Mimura M, Uchida H.

JOURNAL OF AFFECTIVE DISORDERS   2018年( ISSN：0165-0327 )

Effect of Clozapine vs Other Second-Generation Antipsychotics on Hospitalization and Seclusion: A Retrospective Mirror-Image Study in a Japanese Public Psychiatric Hospital. 査読

Misawa F, Suzuki T, Fujii Y.

J Clin Psychopharmacol. 2017 Dec;37(6):664-668. doi: 10.1097/JCP.0000000000000798.   2017年12月

Effects of chair yoga therapy on physical fitness in patients with psychiatric disorders: A 12-week single-blind randomized controlled trial. 査読

Ikai S, Uchida H, Mizuno Y, Tani H, Nagaoka M, Tsunoda K, Mimura M, Suzuki T.

J Psychiatr Res. 2017 Nov;94:194-201. doi: 10.1016/j.jpsychires.2017.07.015.   2017年11月

Patients' Knowledge about Prescribed Antipsychotics and Medication Adherence in Schizophrenia: A Cross-Sectional Survey. 査読

Nagai N, Tani H, Suzuki T, Ikai S, Gerretsen P, Mimura M, Uchida H.

Pharmacopsychiatry. 2017 Nov;50(6):264-269. doi: 10.1055/s-0043-113828.   2017年11月

Quality of life in schizophrenia and bipolar disorder: The impact of symptomatic remission and resilience. 査読

Hofer A, Mizuno Y, Wartelsteiner F, Wolfgang Fleischhacker W, Frajo-Apor B, Kemmler G, Mimura M, Pardeller S, Sondermann C, Suzuki T, Welte A, Uchida H.

Eur Psychiatry. 2017 Oct;46:42-47. doi: 10.1016/j.eurpsy.2017.08.005.   2017年10月

Psychotic Symptoms Associated With Varenicline in a Patient With Alcohol and Nicotine Dependence: A Case Report. 査読

Ueno F, Uchida H, Suzuki T, Yokoyama A, Matsushita S, Mimura M, Higuchi S.

J Clin Psychopharmacol. 2017 Oct;37(5):627-628. doi: 10.1097/JCP.0000000000000771.   2017年10月

Self-rated cognitive functions following chemotherapy in patients with breast cancer: a 6-month prospective study. 査読

Kitahata R, Nakajima S, Uchida H, Hayashida T, Takahashi M, Nio S, Hirano J, Nagaoka M, Suzuki T, Jinno H, Kitagawa Y, Mimura M.

Neuropsychiatr Dis Treat. 2017 Oct 3;13:2489-2496. doi: 10.2147/NDT.S141408. eCollection 2017.   2017年10月

Resilience and spirituality in patients with depression and their family members: A cross-sectional study. 査読

Ozawa C, Suzuki T, Mizuno Y, Tarumi R, Yoshida K, Fujii K, Hirano J, Tani H, Rubinstein EB, Mimura M, Uchida H.

Compr Psychiatry. 2017 Aug;77:53-59. doi: 10.1016/j.comppsych.2017.06.002.   2017年8月

Predicting relapse with individual residual symptoms in major depressive disorder: a reanalysis of the STAR*D data. 査読

Sakurai H, Suzuki T, Yoshimura K, Mimura M, Uchida H.

Psychopharmacology (Berl). 2017 Aug;234(16):2453-2461. doi: 10.1007/s00213-017-4634-5.   2017年8月

Lack of Early Improvement with Antipsychotics is a Marker for Subsequent Nonresponse in Behavioral and Psychological Symptoms of Dementia: Analysis of CATIE-AD Data. 査読

Yoshida K, Roberts R, Suzuki T, Lebowitz B, Reeves S, Howard R, Abe T, Mimura M, Uchida H.

Am J Geriatr Psychiatry. 2017 Jul;25(7):708-716. doi: 10.1016/j.jagp.2017.01.016.   2017年7月

Immediate vs Gradual Discontinuation in Antipsychotic Switching: A Systematic Review and Meta-analysis. 査読

Takeuchi H, Kantor N, Uchida H, Suzuki T, Remington G.

Schizophr Bull. 2017 Jul 1;43(4):862-871. doi: 10.1093/schbul/sbw171.   2017年7月

Kirino S, Suzuki T, Takeuchi H, Mimura M, Uchida H. 査読

Representativeness of clinical PET study participants with schizophrenia: A systematic review.

J Psychiatr Res. 2017 May;88:72-79. doi: 10.1016/j.jpsychires.2016.12.023.   2017年5月

Treatment-Resistant Schizophrenia: Treatment Response and Resistance in Psychosis (TRRIP) Working Group Consensus Guidelines on Diagnosis and Terminology. 査読

Howes OD, McCutcheon R, Agid O, de Bartolomeis A, van Beveren NJ, Birnbaum ML, Bloomfield MA, Bressan RA, Buchanan RW, Carpenter WT, Castle DJ, Citrome L, Daskalakis ZJ, Davidson M, Drake RJ, Dursun S, Ebdrup BH, Elkis H, Falkai P, Fleischacker WW, Gadelha A, Gaughran F, Glenthøj BY, Graff-Guerrero A, Hallak JE, Honer WG, Kennedy J, Kinon BJ, Lawrie SM, Lee J, Leweke FM, MacCabe JH, McNabb CB, Meltzer H, Möller HJ, Nakajima S, Pantelis C, Reis Marques T, Remington G, Rossell SL, Russell BR, Siu CO, Suzuki T, Sommer IE, Taylor D, Thomas N, Üçok A, Umbricht D, Walters JT, Kane J, Correll CU.

Am J Psychiatry. 2017 Mar 1;174(3):216-229. doi: 10.1176/appi.ajp.2016.16050503.   2017年3月

Early Improvement of Specific Symptoms Predicts Subsequent Recovery in Bipolar Depression: Reanalysis of the Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD) Data. 査読

Mizushima J, Uchida H, Tada M, Suzuki T, Mimura M, Nio S.

J Clin Psychiatry. 2017 Feb;78(2):e146-e151. doi: 10.4088/JCP.15m10573.   2017年2月

Cognition and Dopamine D2 Receptor Availability in the Striatum in Older Patients with Schizophrenia. 査読

Rajji TK, Mulsant BH, Nakajima S, Caravaggio F, Suzuki T, Uchida H, Gerretsen P, Mar W, Pollock BG, Mamo DC, Graff-Guerrero A.

Am J Geriatr Psychiatry. 2017 Jan;25(1):1-10. doi: 10.1016/j.jagp.2016.08.001.   2017年1月

Psychological dependence on antidepressants in patients with panic disorder: a cross-sectional study. 査読

Fujii K, Suzuki T, Mimura M, Uchida H.

Int Clin Psychopharmacol. 2017 Jan;32(1):36-40.   2017年1月

Placebo Effects in the Treatment of Noncognitive Symptoms of Alzheimer's Disease: Analysis of the CATIE-AD Data. 査読

Ozawa C, Roberts R, Yoshida K, Suzuki T, Lebowitz B, Reeves S, Howard R, Abe T, Mimura M, Uchida H.

J Clin Psychiatry. 2017 Nov/Dec;78(9):e1204-e1210. doi: 10.4088/JCP.17m11461.   2017年

Prediction Model of Serum Lithium Concentrations. 査読

Yoshida K, Uchida H, Suzuki T, Watanabe M, Yoshino N, Houchi H, Mimura M, Fukuoka N.

Pharmacopsychiatry. 2017 Aug 2. doi: 10.1055/s-0043-116855. [Epub ahead of print]   2017年

Threshold of Dopamine D2/3 Receptor Occupancy for Hyperprolactinemia in Older Patients With Schizophrenia. 査読

Iwata Y, Nakajima S, Caravaggio F, Suzuki T, Uchida H, Plitman E, Chung JK, Mar W, Gerretsen P, Pollock BG, Mulsant BH, Rajji TK, Mamo DC, Graff-Guerrero A.

J Clin Psychiatry. 2016 Dec;77(12):e1557-e1563. doi: 10.4088/JCP.15m10538.   2016年12月

Plasma levels and estimated dopamine D2 receptor occupancy of long-acting injectable risperidone during maintenance treatment of schizophrenia: a 3-year follow-up study. 査読

Ikai S, Suzuki T, Mimura M, Uchida H.

Psychopharmacology (Berl). 2016 Dec;233(23-24):4003-4010.   2016年12月

Increasing Versus Maintaining the Dose of Olanzapine or Risperidone in Schizophrenia Patients Who Did Not Respond to a Modest Dosage: A Double-Blind Randomized Controlled Trial. 査読

Sakurai H, Suzuki T, Bies RR, Pollock BG, Mimura M, Kapur S, Uchida H.

J Clin Psychiatry. 2016 Oct;77(10):1381-1390. doi: 10.4088/JCP.15m10490.   2016年10月

Prescription patterns for depression among consultation-liaison psychiatrists and non-psychiatrists: a chart review. 査読

Ikai S, Suzuki T, Uchida H, Saito H, Mimura M, Takeuchi H.

Int J Geriatr Psychiatry. 2016 Sep;31(9):1084-5. doi: 10.1002/gps.4341.   2016年9月

Early Improvements in Individual Symptoms to Predict Later Remission in Major Depressive Disorder Treated with Mirtazapine. 査読

Funaki K, Nakajima S, Suzuki T, Mimura M, Uchida H.

J Clin Pharmacol. 2016 Sep;56(9):1111-9. doi: 10.1002/jcph.710.   2016年9月

Clinical and biological correlates of resilience in patients with schizophrenia and bipolar disorder: A cross-sectional study. 査読

Mizuno Y, Hofer A, Suzuki T, Frajo-Apor B, Wartelsteiner F, Kemmler G, Saruta J, Tsukinoki K, Mimura M, Fleischhacker WW, Uchida H.

Schizophr Res. 2016 Aug;175(1-3):148-153. doi: 10.1016/j.schres.2016.04.047.   2016年8月

Resilience, internalized stigma, self-esteem, and hopelessness among people with schizophrenia: Cultural comparison in Austria and Japan. 査読

Hofer A, Mizuno Y, Frajo-Apor B, Kemmler G, Suzuki T, Pardeller S, Welte AS, Sondermann C, Mimura M, Wartelsteiner F, Fleischhacker WW, Uchida H.

Schizophr Res. 2016 Mar;171(1-3):86-91. doi: 10.1016/j.schres.2016.01.027.   2016年3月

Resilience in schizophrenia: A comparative study between a remote island and an urban area in Japan 査読

Yoshida K, Suzuki T, Imasaka Y, Kubo KI, Mizuno Y, Saruta J, Tsukinoki K, Mimura M, Uchida H.

Schizophr Res. 2016 Mar;171(1-3):92-6. doi: 10.1016/j.schres.2016.01.030.   2016年3月

Postural sway and flexibility in patients with schizophrenia-spectrum disorders: A cross-sectional study. 査読

Ikai S, Uchida H, Suzuki T, Tsunoda K, Fujii Y, Mimura M.

Asian J Psychiatr. 2016 Feb;19:14-8. doi: 10.1016/j.ajp.2015.11.008.   2016年2月

Dopamine D2/3 Receptor Occupancy Following Dose Reduction Is Predictable With Minimal Plasma Antipsychotic Concentrations: An Open-Label Clinical Trial. 査読

Nakajima S, Uchida H, Bies RR, Caravaggio F, Suzuki T, Plitman E, Mar W, Gerretsen P, Pollock BG, Mulsant BH, Mamo DC, Graff-Guerrero A.

Schizophr Bull. 2016 Jan;42(1):212-9. doi: 10.1093/schbul/sbv106.   2016年1月

A further consideration on long-acting injectable versus oral antipsychotics in the treatment of schizophrenia: a narrative review and critical appraisal 査読

Suzuki T

Expert Opin Drug Deliv. 2016;13(2):253-64. doi: 10.1517/17425247.2016.1115479.   2016年

Relapse of ileus in patients with psychiatric disorders: A 2-year chart review. 査読

Kitahata R, Nakajima S, Suzuki T, Plitman E, Mimura M, Uchida H.

Gen Hosp Psychiatry. 2016 Jan-Feb;38:31-6. doi: 10.1016/j.genhosppsych.2015.09.003.   2016年

Predicting Plasma Olanzapine Concentration Following a Change in Dosage: A Population Pharmacokinetic Study. 査読

Tsuboi T, Bies RR, Suzuki T, Takeuchi H, Nakajima S, Graff-Guerrero A, Mamo DC, Caravaggio F, Plitman E, Mimura M, Pollock BG, Uchida H.

Pharmacopsychiatry. 2015 Nov;48(7):286-91. doi: 10.1055/s-0035-1565070.   2015年11月

Effects of glutamate positive modulators on cognitive deficits in schizophrenia: a systematic review and meta-analysis of double-blind randomized controlled trials. 査読

Iwata Y, Nakajima S, Suzuki T, Keefe RS, Plitman E, Chung JK, Caravaggio F, Mimura M, Graff-Guerrero A, Uchida H.

Mol Psychiatry. 2015 Oct;20(10):1151-60. doi: 10.1038/mp.2015.68.   2015年10月

Antidepressant dose and treatment response in bipolar depression: Reanalysis of the Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD) data. 査読

Tada M, Uchida H, Mizushima J, Suzuki T, Mimura M, Nio S.

J Psychiatr Res. 2015 Sep;68:151-6. doi: 10.1016/j.jpsychires.2015.06.015.   2015年9月

Evaluation of Antipsychotic Dose Reduction in Late-Life Schizophrenia: A Prospective Dopamine D2/3 Receptor Occupancy Study. 査読

Graff-Guerrero A, Rajji TK, Mulsant BH, Nakajima S, Caravaggio F, Suzuki T, Uchida H, Gerretsen P, Mar W, Pollock BG, Mamo DC.

JAMA Psychiatry. 2015 Sep;72(9):927-34. doi: 10.1001/jamapsychiatry.2015.0891.   2015年9月

Language Barriers and Access to Psychiatric Care: A Systematic Review. 査読

Ohtani A, Suzuki T, Takeuchi H, Uchida H.

Psychiatr Serv. 2015 Aug 1;66(8):798-805. doi: 10.1176/appi.ps.201400351.   2015年8月

Optimization of psychopharmacotherapy for schizophrenia in a male, locked, non-acute unit serving for persistently ill patients over one year. 査読

Suzuki T, Uchida H, Takeuchi H, Tsunoda K, Ishizuki T, Mimura M.

Psychiatry Res. 2015 Jul 30;228(1):26-30. doi: 10.1016/j.psychres.2015.03.019.   2015年7月

A questionnaire survey of Japanese non-psychiatrists' attitudes on management of depression in a general hospital. 査読

Ikai S, Suzuki T, Uchida H, Saito H, Mimura M, Takeuchi H.

Asian J Psychiatr. 2015 Jun;15:73-4. doi: 10.1016/j.ajp.2015.04.003.   2015年6月

Relationships between global assessment of functioning and other rating scales in clinical trials for schizophrenia. 査読

Suzuki T, Uchida H, Sakurai H, Ishizuki T, Tsunoda K, Takeuchi H, Mimura M.

Psychiatry Res. 2015 Jun 30;227(2-3):265-9. doi: 10.1016/j.psychres.2015.02.024.   2015年6月

Antipsychotic Polypharmacy and Corrected QT Interval: A Systematic Review. 査読

Takeuchi H, Suzuki T, Remington G, Uchida H.

Can J Psychiatry. 2015 May;60(5):215-22.   2015年5月

Dopamine D2/3 receptor availability in the striatum of antipsychotic-free older patients with schizophrenia-A [11C]-raclopride PET study. 査読

Nakajima S, Caravaggio F, Mamo DC, Mulsant BH, Chung JK, Plitman E, Iwata Y, Gerretsen P, Uchida H, Suzuki T, Mar W, Wilson AA, Houle S, Graff-Guerrero A.

Schizophr Res. 2015 May;164(1-3):263-7. doi: 10.1016/j.schres.2015.02.020.   2015年5月

Challenging the need for sustained blockade of dopamine D2 receptor estimated from antipsychotic plasma levels in the maintenance treatment of schizophrenia: A single-blind, randomized, controlled study. 査読

Tsuboi T, Suzuki T, Bies RR, Remington G, Pollock BG, Mimura M, Uchida H.

Schizophr Res. 2015 May;164(1-3):149-54. doi: 10.1016/j.schres.2015.03.025.   2015年5月

Cardiac Sudden Death in Psychiatric Patients.

Uchida H, Suzuki T.

Can J Psychiatry. 2015 May;60(5):203-5.   2015年5月

Whether to increase or maintain dosage of mirtazapine in early nonimprovers with depression. 査読

Ueno F, Nakajima S, Suzuki T, Abe T, Sato Y, Mimura M, Uchida H.

J Clin Psychiatry. 2015 Apr;76(4):434-439. doi: 10.4088/JCP.14m09201.   2015年4月

Dependence on Benzodiazepines in Patients with Panic Disorder: A Cross-Sectional Study. 査読

Fujii K, Uchida H, Suzuki T, Mimura M.

Psychiatry Clin Neurosci. 2015 Feb;69(2):93-9. doi: 10.1111/pcn.12203.   2015年2月

Therapeutic Window for Striatal Dopamine D2/3 Receptor Occupancy in Older Patients with Schizophrenia: A Pilot PET Study. 査読

Uchida H, Suzuki T, Graff-Guerrero A, Mulsant BH, Pollock BG, Arenovich T, Rajji TK, Mamo DC.

Am J Geriatr Psychiatry. 2014 Oct;22(10):1007-16. doi: 10.1016/j.jagp.2013.01.045.   2014年12月

Dose and Dosing Frequency of Long-Acting Injectable Antipsychotics: A Systematic Review of PET and SPECT Data and Clinical Implications. 査読

Uchida H, Suzuki T.

J Clin Psychopharmacol. 2014 Dec;34(6):728-35. doi: 10.1097/JCP.0000000000000065.   2014年12月

Successful withdrawal from antipsychotic treatment in elderly male inpatients with schizophrenia-Description of four cases and review of the literature. 査読

Suzuki T, Uchida H.

Psychiatry Res. 2014 Dec 15;220(1-2):152-7. doi: 10.1016/j.psychres.2014.08.024.   2014年12月

Ikai S, Suzuki T, Uchida H, Saruta J, Tsukinoki K, Fujii Y, Mimura M. 査読

Effects of Weekly One-Hour Hatha Yoga Therapy on Resilience and Stress Levels in Patients with Schizophrenia-Spectrum Disorders: An Eight-Week Randomized Controlled Trial.

J Altern Complement Med. 2014 Nov;20(11):823-30. doi: 10.1089/acm.2014.0205.   2014年11月

Timing of Adjunctive Therapy in the Treatment of Depression: A Chart Review. 査読

Tarumi R, Suzuki T, Tani H, Den R, Sawada N, Sakurai H, Tsutsumi-Ozawa C, Ohtani A, Mimura M, Uchida H.

Pharmacopsychiatry. 2014 Nov;47(7):259-62. doi: 10.1055/s-0034-1387784.   2014年11月

Pharmacological Strategies to Counteract Antipsychotic-Induced Weight Gain and Metabolic Adverse Effects in Schizophrenia: A Systematic Review and Meta-analysis. 査読

Mizuno Y, Suzuki T, Nakagawa A, Yoshida K, Mimura M, Fleischhacker WW, Uchida H.

Schizophr Bull. 2014 Nov;40(6):1385-403. doi: 10.1093/schbul/sbu030.   2014年11月

Dose reduction of risperidone and olanzapine and estimated dopamine D₂ receptor occupancy in stable patients with schizophrenia: findings from an open-label, randomized, controlled study. 査読

Takeuchi H, Suzuki T, Bies RR, Remington G, Watanabe K, Mimura M, Uchida H.

J Clin Psychiatry. 2014 Nov;75(11):1209-14. doi: 10.4088/JCP.13m08841.   2014年11月

Antipsychotic medications for schizophrenia.

Suzuki T.

JAMA. 2014 Oct 8;312(14):1468-9. doi: 10.1001/jama.2014.10103.   2014年10月

A review on schizophrenia and relapse -a quest for user-friendly psychopharmacotherapy. 査読

Suzuki T, Uchida H, Takeuchi H, Tsuboi T, Hirano J, Mimura M.

Hum Psychopharmacol. 2014 Sep;29(5):414-26.   2014年9月

Lack of Effect of Risperidone or Olanzapine Dose Reduction on Metabolic Parameters, Prolactin, and Corrected QT Interval in Stable Patients With Schizophrenia. 査読

Takeuchi H, Suzuki T, Remington G, Watanabe K, Mimura M, Uchida H.

J Clin Psychopharmacol. 2014 Aug;34(4):517-20. doi: 10.1097/JCP.0000000000000142.   2014年8月

Lack of effect of risperidone or olanzapine dose reduction on subjective experiences in stable patients with schizophrenia. 査読

Takeuchi H, Suzuki T, Remington G, Watanabe K, Mimura M, Uchida H.

Psychiatry Res. 2014 Aug 15;218(1-2):244-6. doi: 10.1016/j.psychres.2014.04.019.   2014年8月

Baseline Difference Between Patients' and Clinicians' Rated Illness Severity Scores and Subsequent Outcomes in Major Depressive Disorder: Analysis of the Sequenced Treatment Alternatives to Relieve Depression Data. 査読

Tada M, Uchida H, Suzuki T, Abe T, Pollock BG, Mimura M.

J Clin Psychopharmacol. 2014 Jun;34(3):297-302. doi: 10.1097/JCP.0000000000000112.   2014年6月

Impact of once- versus twice-daily perphenazine dosing on clinical outcomes: an analysis of the CATIE data. 査読

Takeuchi H, Fervaha G, Uchida H, Suzuki T, Bies RR, Grönte D, Remington G.

J Clin Psychiatry. 2014 May;75(5):506-11. doi: 10.4088/JCP.13m08695.   2014年3月

Tardive dyskinesia in relation to estimated dopamine D2 receptor occupancy in patients with schizophrenia: Analysis of the CATIE data. 査読

Yoshida K, Bies RR, Suzuki T, Remington G, Pollock BG, Mizuno Y, Mimura M, Uchida H.

Schizophr Res. 2014 Mar;153(1-3):184-8. doi: 10.1016/j.schres.2014.01.017.   2014年3月

Prophylactic use of heparin for deep vein thrombosis in restrained psychiatric patients: a chart review. 査読

Ishida T, Suzuki T, Watanabe K, Sakurai H, Uchida H, Mimura M.

Gen Hosp Psychiatry. 2014 Nov-Dec;36(6):690-3. doi: 10.1016/j.genhosppsych.2014.06.007.   2014年

Effectiveness of saikokaryukotsuboreito (herbal medicine) for antipsychotic-induced sexual dysfunction in male patients with schizophrenia: a description of two cases. 査読

Takashi T, Uchida H, Suzuki T, Mimura M.

Case Rep Psychiatry. 2014;2014:784671. doi: 10.1155/2014/784671.   2014年

Estimated dopamine D2 receptor occupancy from plasma concentrations of atypical antipsychotics and subjective experience/drug attitude in schizophrenia: an analysis of the CATIE data. 査読

Takeuchi H, Suzuki T, Bies RR, Remington G, Mamo DC, Pollock BG, Mimura M, Uchida H.

Schizophr Res. 2013 Nov;150(2-3):373-9. doi: 10.1016/j.schres.2013.08.033.   2013年11月

Association between antidepressant side effects and functional impairment in patients with major depressive disorders. 査読

Kikuchi T, Suzuki T, Uchida H, Watanabe K, Mimura M.

Psychiatry Res. 2013 Nov 30;210(1):127-33. doi: 10.1016/j.psychres.2013.05.007.   2013年11月

Trajectories of individual symptoms in remitters versus non-remitters with depression. 査読

Sakurai H, Uchida H, Abe T, Nakajima S, Suzuki T, Pollock BG, Sato Y, Mimura M.

J Affect Disord. 2013 Nov;151(2):506-13. doi: 10.1016/j.jad.2013.06.035.   2013年11月

Effects of yoga therapy on postural stability in patients with schizophrenia-spectrum disorders: A single-blind randomized controlled trial. 査読

Ikai S, Uchida H, Suzuki T, Tsunoda K, Mimura M, Fujii Y.

J Psychiatr Res. 2013 Nov;47(11):1744-50. doi: 10.1016/j.jpsychires.2013.07.017.   2013年11月

Estimated dopamine D₂ receptor occupancy and remission in schizophrenia: analysis of the CATIE data. 査読

Moriguchi S, Bies RR, Remington G, Suzuki T, Mamo DC, Watanabe K, Mimura M, Pollock BG, Uchida H.

J Clin Psychopharmacol. 2013 Oct;33(5):682-5. doi: 10.1097/JCP.0b013e3182979a0a.   2013年10月

Effects of risperidone and olanzapine dose reduction on cognitive function in stable patients with schizophrenia: an open-label, randomized, controlled, pilot study. 査読

Takeuchi H, Suzuki T, Remington G, Bies RR, Abe T, Graff-Guerrero A, Watanabe K, Mimura M, Uchida H.

Schizophr Bull. 2013 Sep;39(5):993-8. doi: 10.1093/schbul/sbt090.   2013年9月

Ten year outcomes of outpatients with schizophrenia on conventional depot antipsychotics: a systematic chart review. 査読

Uchida T, Suzuki T, Sakurai H, Tsutsumi C, Den R, Mimura M, Uchida H.

Int Clin Psychopharmacol. 2013 Sep;28(5):261-6. doi: 10.1097/YIC.0b013e328363aa5a.   2013年9月

Absence of evidence that the pro re nata regimen confers benefit: a review of the studies.

Yoshida K, Suzuki T, Uchida H, Mimura M.

Int Clin Psychopharmacol. 2013 Sep;28(5):228-37. doi: 10.1097/YIC.0b013e328362db99.   2013年9月

Hyperprolactinemia and estimated dopamine D2 receptor occupancy in patients with schizophrenia: analysis of the CATIE data. 査読

Tsuboi T, Bies RR, Suzuki T, Mamo DC, Pollock BG, Graff-Guerrero A, Mimura M, Uchida H.

Prog Neuropsychopharmacol Biol Psychiatry. 2013 Aug 1;45:178-82. doi: 10.1016/j.pnpbp.2013.05.010.   2013年8月

Dopamine D₂/₃ occupancy of ziprasidone across a day: a within-subject PET study. 査読

Suzuki T, Graff-Guerrero A, Uchida H, Remington G, Caravaggio F, Borlido C, Pollock B, Mulsant B, Deluca V, Ismail Z, Mamo D.

Psychopharmacology (Berl). 2013 Jul;228(1):43-51. doi: 10.1007/s00213-013-3012-1.   2013年6月

Dopamine D2 receptor occupancy and cognition in schizophrenia: analysis of the CATIE data. 査読

Sakurai H, Bies RR, Stroup ST, Keefe RS, Rajji TK, Suzuki T, Mamo DC, Pollock BG, Watanabe K, Mimura M, Uchida H.

Schizophr Bull. 2013 May;39(3):564-74. doi: 10.1093/schbul/sbr189.   2013年5月

Factor structure of the targeted inventory on problems in schizophrenia. 査読

Tanaka S, Nagase T, Suzuki T, Nomura K, Takeuchi H, Nakajima S, Uchida H, Yagi G, Watanabe K, Mimura M.

Clin Psychopharmacol Neurosci. 2013 Apr;11(1):18-23. doi: 10.9758/cpn.2013.11.1.18.   2013年4月

Interventions to reduce antipsychotic polypharmacy: a systematic review. 査読

Tani H, Uchida H, Suzuki T, Fujii Y, Mimura M.

Schizophr Res. 2013 Jan;143(1):215-20. doi: 10.1016/j.schres.2012.10.015.   2013年1月

An open-label study of algorithm-based treatment versus treatment-as-usual for patients with schizophrenia. 査読

Hirano J, Watanabe K, Suzuki T, Uchida H, Den R, Kishimoto T, Nagasawa T, Tomita Y, Hara K, Ochi H, Kobayashi Y, Ishii M, Fujita A, Kanai Y, Goto M, Hayashi H, Inamura K, Ooshima F, Sumida M, Ozawa T, Sekigawa K, Nagaoka M, Yoshimura K, Konishi M, Inagaki A, Saito T, Motohashi N, Mimura M, Okubo Y, Kato M.

Neuropsychiatr Dis Treat. 2013;9:1553-64. doi: 10.2147/NDT.S46108.   2013年

Reintroduction of clozapine after perforation of the large intestine--a case report and review of the literature. 査読

Ikai S, Suzuki T, Uchida H, Mimura M, Fujii Y.

Ann Pharmacother. 2013 Jul-Aug;47(7-8):e31. doi: 10.1345/aph.1S117.   2013年

Oversight of constipation in inpatients with schizophrenia: a cross-sectional study. 査読

Koizumi T, Uchida H, Suzuki T, Sakurai H, Tsunoda K, Nishimoto M, Ishigaki T, Goto A, Mimura M.

Gen Hosp Psychiatry. 2013 Nov-Dec;35(6):649-52. doi: 10.1016/j.genhosppsych.2013.06.007.   2013年

Coping strategies for antidepressant side effects: an Internet survey. 査読

Kikuchi T, Suzuki T, Uchida H, Watanabe K, Mimura M.

J Affect Disord. 2012 Dec 20;143(1-3):89-94. doi: 10.1016/j.jad.2012.04.039.   2012年12月

Deficit status in bipolar disorder: investigation on prevalence rate and description of seven cases. 査読

Nio S, Suzuki T, Uchida H, Watanabe K, Mimura M.

J Affect Disord. 2012 Dec 20;143(1-3):248-52. doi: 10.1016/j.jad.2012.05.037.   2012年12月

A cross-sectional study of plasma risperidone levels with risperidone long-acting injectable: implications for dopamine D2 receptor occupancy during maintenance treatment in schizophrenia. 査読

Ikai S, Remington G, Suzuki T, Takeuchi H, Tsuboi T, Den R, Hirano J, Tsunoda K, Nishimoto M, Watanabe K, Mimura M, Mamo D, Uchida H.

J Clin Psychiatry. 2012 Aug;73(8):1147-52. doi: 10.4088/JCP.12m07638.   2012年8月

Dental conditions in inpatients with schizophrenia: a large-scale multi-site survey. 査読

Tani H, Uchida H, Suzuki T, Shibuya Y, Shimanuki H, Watanabe K, Den R, Nishimoto M, Hirano J, Takeuchi H, Nio S, Nakajima S, Kitahata R, Tsuboi T, Tsunoda K, Kikuchi T, Mimura M.

BMC Oral Health. 2012 Aug 18;12:32. doi: 10.1186/1472-6831-12-32.   2012年8月

How psychotropic polypharmacy in schizophrenia begins: a longitudinal perspective. 査読

Shinfuku M, Uchida H, Tsutsumi C, Suzuki T, Watanabe K, Kimura Y, Tsutsumi Y, Ishii K, Imasaka Y, Mimura M, Kapur S.

Pharmacopsychiatry. 2012 Jun;45(4):133-7. doi: 10.1055/s-0031-1297934.   2012年6月

Discontinuing donepezil or starting memantine for Alzheimer's disease.

Suzuki T.

N Engl J Med. 2012 Jun 7;366(23):2227-8; author reply 2228. doi: 10.1056/NEJMc1204656#SA1.   2012年6月

Defining treatment-resistant schizophrenia and response to antipsychotics: a review and recommendation. 査読

Suzuki T, Remington G, Mulsant BH, Uchida H, Rajji TK, Graff-Guerrero A, Mimura M, Mamo DC.

Psychiatry Res. 2012 May 15;197(1-2):1-6. doi: 10.1016/j.psychres.2012.02.013.   2012年5月

Predicting plasma concentration of risperidone associated with dosage change: a population pharmacokinetic study. 査読

Uchida H, Mamo DC, Pollock BG, Suzuki T, Tsunoda K, Watanabe K, Mimura M, Bies RR.

Ther Drug Monit. 2012 Apr;34(2):182-7. doi: 10.1097/FTD.0b013e3182489a6f.   2012年4月

Dopamine D2 receptor occupancy with risperidone or olanzapine during maintenance treatment of schizophrenia: a cross-sectional study. 査読

Mizuno Y, Bies RR, Remington G, Mamo DC, Suzuki T, Pollock BG, Tsuboi T, Watanabe K, Mimura M, Uchida H.

Prog Neuropsychopharmacol Biol Psychiatry. 2012 Apr 27;37(1):182-7. doi: 10.1016/j.pnpbp.2011.12.013.   2012年4月

Effects of zonisamide on tardive dyskinesia: a preliminary open-label trial. 査読

Iwata Y, Irie S, Uchida H, Suzuki T, Watanabe K, Iwashita S, Mimura M.

J Neurol Sci. 2012 Apr 15;315(1-2):137-40. doi: 10.1016/j.jns.2011.12.010.   2012年4月

How successful are physicians in eliciting the truth from their patients? A large-scale Internet survey from patients' perspectives. 査読

Sawada N, Uchida H, Watanabe K, Kikuchi T, Suzuki T, Kashima H, Mimura M.

J Clin Psychiatry. 2012 Mar;73(3):311-7. doi: 10.4088/JCP.11m07078.   2012年3月

Antipsychotic treatment for schizophrenia in the maintenance phase: a systematic review of the guidelines and algorithms. 査読

Takeuchi H, Suzuki T, Uchida H, Watanabe K, Mimura M.

Schizophr Res. 2012 Feb;134(2-3):219-25. doi: 10.1016/j.schres.2011.11.021.   2012年2月

Asymptomatic deep vein thrombosis in a patient with major depressive disorder. 査読

Ishida T, Katagiri T, Uchida H, Suzuki T, Watanabe K, Mimura M.

Case Rep Psychiatry. 2012;2012:261251. doi: 10.1155/2012/261251.   2012年

Impact of feedback from pharmacists in reducing antipsychotic polypharmacy in schizophrenia. 査読

Hazra M, Uchida H, Sproule B, Remington G, Suzuki T, Mamo DC.

Psychiatry Clin Neurosci. 2011 Dec;65(7):676-8. doi: 10.1111/j.1440-1819.2011.02280.x.   2011年12月

Management of schizophrenia in late life with antipsychotic medications: a qualitative review 査読

Suzuki T, Remington G, Uchida H, Rajji TK, Graff-Guerrero A, Mamo DC.

Drugs Aging. 2011 Dec 1;28(12):961-80. doi: 10.2165/11595830-000000000-00000.   2011年12月

Treatment resistant schizophrenia and response to antipsychotics: a review 査読

Suzuki T, Remington G, Mulsant BH, Rajji TK, Uchida H, Graff-Guerrero A, Mamo DC.

Schizophr Res. 2011 Dec;133(1-3):54-62. doi: 10.1016/j.schres.2011.09.016.   2011年12月

Patient's trust in their psychiatrist: a cross-sectional survey. 査読

Minamisawa A, Suzuki T, Watanabe K, Imasaka Y, Kimura Y, Takeuchi H, Nakajima S, Kashima H, Uchida H.

Eur Arch Psychiatry Clin Neurosci. 2011 Dec;261(8):603-8. doi: 10.1007/s00406-011-0199-1.   2011年12月

Subjective recognition of adverse events with antidepressant in people with depression: a prospective study. 査読

Kikuchi T, Suzuki T, Uchida H, Watanabe K, Kashima H.

J Affect Disord. 2011 Dec;135(1-3):347-53. doi: 10.1016/j.jad.2011.07.011.   2011年12月

Is switching antidepressants following early nonresponse more beneficial in acute-phase treatment of depression?: a randomized open-label trial. 査読

Nakajima S, Uchida H, Suzuki T, Watanabe K, Hirano J, Yagihashi T, Takeuchi H, Abe T, Kashima H, Mimura M.

Prog Neuropsychopharmacol Biol Psychiatry. 2011 Dec 1;35(8):1983-9. doi: 10.1016/j.pnpbp.2011.08.008.   2011年12月

Time course of improvement with antipsychotic medication in treatment-resistant schizophrenia

Suzuki T, Remington G, Arenovich T, Uchida H, Agid O, Graff-Guerrero A, Mamo DC.

Br J Psychiatry. 2011 Oct;199(4):275-80. doi: 10.1192/bjp.bp.110.083907.   2011年10月

Plasma substance P level in patients with schizophrenia: a cross-sectional study. 査読

Ishida T, Uchida H, Suzuki T, Nakajima S, Watanabe K, Kashima H.

Psychiatry Clin Neurosci. 2011 Aug;65(5):526-8. doi: 10.1111/j.1440-1819.2011.02244.x.   2011年8月

How long to wait before reducing antipsychotic dosage in stabilized patients with schizophrenia? A retrospective chart review. 査読

Takeuchi H, Suzuki T, Uchida H, Kikuchi T, Nakajima S, Manki H, Watanabe K, Kashima H.

J Psychiatr Res. 2011 Aug;45(8):1083-8. doi: 10.1016/j.jpsychires.2011.01.007.   2011年8月

The evolution of antipsychotic switch and polypharmacy in natural practice - a longitudinal perspective. 査読

Tsutsumi C, Uchida H, Suzuki T, Watanabe K, Takeuchi H, Nakajima S, Kimura Y, Tsutsumi Y, Ishii K, Imasaka Y, Kapur S.

Schizophr Res. 2011 Aug;130(1-3):40-6. doi: 10.1016/j.schres.2011.05.013.   2011年8月

Dopamine D2 receptor occupancy and clinical effects: a systematic review and pooled analysis. 査読

Uchida H, Takeuchi H, Graff-Guerrero A, Suzuki T, Watanabe K, Mamo DC.

J Clin Psychopharmacol. 2011 Aug;31(4):497-502. doi: 10.1097/JCP.0b013e3182214aad.   2011年8月

Low dose vs standard dose of antipsychotics for relapse prevention in schizophrenia: meta-analysis. 査読

Uchida H, Suzuki T, Takeuchi H, Arenovich T, Mamo DC.

Schizophr Bull. 2011 Jul;37(4):788-99. doi: 10.1093/schbul/sbp149.   2011年7月

Metabolic syndrome in inpatients treated with clozapine.

Suzuki T.

J Clin Psychiatry. 2011 Jun;72(6):872-3; author reply 873-4. doi: 10.4088/JCP.11lr06864.   2011年6月

A tipping point in drug dosing in late-life schizophrenia.

Tsuboi T, Suzuki T, Uchida H.

Curr Psychiatry Rep. 2011 Jun;13(3):225-33. doi: 10.1007/s11920-011-0189-z.   2011年6月

Predicting dopamine D₂ receptor occupancy from plasma levels of antipsychotic drugs: a systematic review and pooled analysis. 査読

Uchida H, Takeuchi H, Graff-Guerrero A, Suzuki T, Watanabe K, Mamo DC.

J Clin Psychopharmacol. 2011 Jun;31(3):318-25. doi: 10.1097/JCP.0b013e318218d339.   2011年6月

An importance of dose in antipsychotic combination therapy for schizophrenia.

Suzuki T.

J Clin Psychopharmacol. 2011 Jun;31(3):399; author reply 399-400. doi: 10.1097/JCP.0b013e318218f42a.   2011年6月

Long-acting risperidone and oral antipsychotics in schizophrenia.

Suzuki T.

N Engl J Med. 2011 Jun 9;364(23):2265; author reply 265-6. doi: 10.1056/NEJMc1103917#SA2.   2011年6月

Patients' attitudes toward side effects of antidepressants: an Internet survey. 査読

Kikuchi T, Uchida H, Suzuki T, Watanabe K, Kashima H.

Eur Arch Psychiatry Clin Neurosci. 2011 Mar;261(2):103-9. doi: 10.1007/s00406-010-0124-z.   2011年3月

Clinical and demographic characteristics associated with postural instability in patients with schizophrenia. 査読

Koreki A, Tsunoda K, Suzuki T, Hirano J, Watanabe K, Kashima H, Uchida H.

J Clin Psychopharmacol. 2011 Feb;31(1):16-21. doi: 10.1097/JCP.0b013e318205e192.   2011年2月

Risks of intermittent antipsychotic treatment in schizophrenia.

Suzuki T, Nomura K, Watanabe K.

J Clin Psychiatry. 2011 Jan;72(1):114; author reply 114-5. doi: 10.4088/JCP.10lr06452ye.   2011年1月

Maternal depression and child development after prenatal DHA supplementation.

Suzuki T.

JAMA. 2011 Jan 26;305(4):359-60; author reply 360-1. doi: 10.1001/jama.2011.17.   2011年1月

Factors associated with response to clozapine in schizophrenia: a review. 査読

Suzuki T, Uchida H, Watanabe K, Kashima H.

Psychopharmacol Bull. 2011;44(1):32-60.   2011年

Which rating scales are regarded as 'the standard' in clinical trials for schizophrenia? 査読

Suzuki T.

Psychopharmacol Bull. 2011;44(1):18-31.   2011年

Effects of discontinuing benzodiazepine-derivative hypnotics on postural sway and cognitive functions in the elderly. 査読

Tsunoda K, Uchida H, Suzuki T, Watanabe K, Yamashima T, Kashima H.

Int J Geriatr Psychiatry. 2010 Dec;25(12):1259-65. doi: 10.1002/gps.2465.   2010年12月

Is there a real difference in severity of tardive dyskinesia between risperidone and olanzapine?

Suzuki T, Takeuchi H, Watanabe K.

J Clin Psychiatry. 2010 Nov;71(11):1553-4; author reply 1554. doi: 10.4088/JCP.10lr06261yel.   2010年11月

Suzuki T, Takeuchi H, Nakajima S, Nomura K, Uchida H, Yagi G, Watanabe K, Kashima H. 査読

Magnitude of rater differences in assessment scales for schizophrenia.

J Clin Psychopharmacol. 2010 Oct;30(5):607-11. doi: 10.1097/JCP.0b013e3181f0bae1.   2010年10月

Analysis of antipsychotic dose reduction.

Uchida H, Suzuki T, Takeuchi H, Mamo DC.

2010 Aug;167(8):994; author reply 994-5. doi: 10.1176/appi.ajp.2010.10030409.   2010年8月

Depression severity and effect of antidepressant medications.

Suzuki T, Uchida H, Nakajima S.

JAMA. 2010 Apr 28;303(16):1597-8; author reply 1599. doi: 10.1001/jama.2010.507.   2010年4月

Accelerating response to antidepressant treatment in depression: a review and clinical suggestions. 査読

Nakajima S, Suzuki T, Watanabe K, Kashima H, Uchida H.

Prog Neuropsychopharmacol Biol Psychiatry. 2010 Mar 17;34(2):259-64. doi: 10.1016/j.pnpbp.2009.12.001.   2010年3月

Sensitivity to antipsychotic drugs in older adults.

Leon C, Gerretsen P, Uchida H, Suzuki T, Rajji T, Mamo DC.

Curr Psychiatry Rep. 2010 Feb;12(1):28-33. doi: 10.1007/s11920-009-0080-3.   2010年2月

Changes in metabolic parameters following a switch to aripiprazole in Japanese patients with schizophrenia: One-year follow-up study. 査読

Takeuchi H, Uchida H, Suzuki T, Watanabe K, Kashima H.

Psychiatry Clin Neurosci. 2010 Feb;64(1):104-6. doi: 10.1111/j.1440-1819.2009.02036.x.   2010年2月

Augmentation of atypical antipsychotics with valproic acid. An open-label study for most difficult patients with schizophrenia. 査読

Suzuki T, Uchida H, Takeuchi H, Nakajima S, Nomura K, Tanabe A, Yagi G, Watanabe K, Kashima H.

Hum Psychopharmacol. 2009 Dec;24(8):628-38. doi: 10.1002/hup.1073.   2009年12月

Impacts of switching antidepressants after successful electroconvulsive therapy on the maintenance of clinical remission in patients with treatment-resistant depression: a chart review. 査読

Nakajima S, Ishida T, Akaishi R, Takahata K, Kitahata R, Uchida H, Suzuki T, Takeuchi H, Nomura K, Nakagawa A, Watanabe K, Kashima H.

J ECT. 2009 Sep;25(3):178-81. doi: 10.1097/YCT.0b013e3181a8e2ac.   2009年9月

Selective serotonin reuptake inhibitor-induced spermatorrhea in 2 patients. 査読

Nakajima S, Uchida H, Suzuki T, Watanabe K, Kashima H.

J Clin Psychiatry. 2009 Aug;70(8):1192-3. doi: 10.4088/JCP.09l05007.   2009年8月

Predictors of clinical worsening after a switch to aripiprazole in patients with schizophrenia: a 1-year naturalistic follow-up study. 査読

Takeuchi H, Uchida H, Suzuki T, Watanabe K, Kashima H.

J Clin Psychopharmacol. 2009 Aug;29(4):394-5. doi: 10.1097/JCP.0b013e3181accfec.   2009年8月

Persistence and compliance to antidepressant treatment in patients with depression: a chart review. 査読

Sawada N, Uchida H, Suzuki T, Watanabe K, Kikuchi T, Handa T, Kashima H.

BMC Psychiatry. 2009 Jun 16;9:38. doi: 10.1186/1471-244X-9-38.   2009年6月

Benzodiazepine and antidepressant use in elderly patients with anxiety disorders: a survey of 796 outpatients in Japan. 査読

Uchida H, Suzuki T, Mamo DC, Mulsant BH, Kikuchi T, Takeuchi H, Tomita M, Watanabe K, Yagi G, Kashima H.

J Anxiety Disord. 2009 May;23(4):477-81. doi: 10.1016/j.janxdis.2008.10.003.   2009年5月

Survey of benzodiazepine and antidepressant use in outpatients with mood disorders in Japan. 査読

Uchida H, Suzuki T, Mamo DC, Mulsant BH, Tsunoda K, Takeuchi H, Kikuchi T, Nakajima S, Nomura K, Tomita M, Watanabe K, Kashima H.

Psychiatry Clin Neurosci. 2009 Apr;63(2):244-6. doi: 10.1111/j.1440-1819.2008.01920.x.   2009年4月

Should adjunctive antipsychotic treatment be continued in remitted patients with depression? 査読

Uchida H, Suzuki T, Watanabe K, Kashima H.

Psychiatry Clin Neurosci. 2009 Feb;63(1):126. doi: 10.1111/j.1440-1819.2008.01897.x.   2009年2月

Antipsychotic-induced paroxysmal perceptual alteration in a patient with bipolar disorder. 査読

Nakajima S, Suzuki T, Uchida H, Watanabe K, Kashima H.

Prog Neuropsychopharmacol Biol Psychiatry. 2009 Feb 1;33(1):160-1. doi: 10.1016/j.pnpbp.2008.10.021.   2009年2月

Novel rating scales for schizophrenia - Targeted Inventory on Problems in Schizophrenia (TIP-Sz) and Functional Assessment for Comprehensive Treatment of Schizophrenia (FACT-Sz). 査読

Suzuki T, Uchida H, Nomura K, Takeuchi H, Nakajima S, Tanabe A, Yagi G, Watanabe K, Kashima H.

Schizophr Res. 2008 Dec;106(2-3):328-36. doi: 10.1016/j.schres.2008.08.013.   2008年12月

A randomized, open-label comparison of 2 switching strategies to aripiprazole treatment in patients with schizophrenia: add-on, wait, and tapering of previous antipsychotics versus add-on and simultaneous tapering. 査読

Takeuchi H, Suzuki T, Uchida H, Nakajima S, Nomura K, Kikuchi T, Manki H, Watanabe K, Kashima H.

J Clin Psychopharmacol. 2008 Oct;28(5):540-3. doi: 10.1097/JCP.0b013e3181842586.   2008年10月

Effectiveness of antipsychotic polypharmacy for patients with treatment refractory schizophrenia: an open-label trial of olanzapine plus risperidone for those who failed to respond to a sequential treatment with olanzapine, quetiapine and risperidone. 査読

Suzuki T, Uchida H, Watanabe K, Nakajima S, Nomura K, Takeuchi H, Tanabe A, Yagi G, Kashima H.

Hum Psychopharmacol. 2008 Aug;23(6):455-63. doi: 10.1002/hup.959.   2008年8月

Effects of age and age of onset on prescribed antipsychotic dose in schizophrenia spectrum disorders: a survey of 1,418 patients in Japan. 査読

Uchida H, Suzuki T, Mamo DC, Mulsant BH, Tanabe A, Inagaki A, Watanabe K, Yagi G, Tomita M.

Am J Geriatr Psychiatry. 2008 Jul;16(7):584-93. doi: 10.1097/JGP.0b013e318172b42d.   2008年7月

A potentially aborted neuroleptic malignant syndrome following seclusion against uncontrollable water intoxication. 査読

Suzuki T, Uchida H, Watanabe K, Kashima H.

Psychopharmacol Bull. 2008;41(1):164-70.   2008年1月

Treatment target in schizophrenia: a critical review and a clinical suggestion. 査読

Suzuki T, Uchida H, Watanabe K, Kashima H.

Psychopharmacol Bull. 2008;41(4):80-102.   2008年

How effective is it to sequentially switch among Olanzapine, Quetiapine and Risperidone?--A randomized, open-label study of algorithm-based antipsychotic treatment to patients with symptomatic schizophrenia in the real-world clinical setting. 査読

Suzuki T, Uchida H, Watanabe K, Nomura K, Takeuchi H, Tomita M, Tsunoda K, Nio S, Den R, Manki H, Tanabe A, Yagi G, Kashima H.

Psychopharmacology (Berl). 2007 Dec;195(2):285-95.   2007年12月

Minimizing antipsychotic medication obviated the need for enema against severe constipation leading to paralytic ileus: a case report. 査読

Suzuki T, Uchida H, Watanabe K, Kashima H.

J Clin Pharm Ther. 2007 Oct;32(5):525-7.   2007年10月

An open-label trial of discontinuing benzodiazepines in patients with chronic schizophrenia. 査読

Nakajima S, Uchida H, Suzuki T, Tomita M, Tsunoda K, Kitta M, Takeuchi H, Nomura K, Watanabe K, Kashima H.

J Clin Psychopharmacol. 2007 Aug;27(4):401-3.   2007年8月

Treating a schizophrenic patient with severe tardive dystonia without antipsychotics. 査読

Suzuki T, Uchida H, Watanabe K, Kashima H.

Prog Neuropsychopharmacol Biol Psychiatry. 2007 Jun 30;31(5):1141-2.   2007年6月

Antipsychotics-induced hypersensitivity of visual perception. 査読

Uchida H, Suzuki T, Watanabe K, Kashima H.

Eur Psychiatry. 2006 Jul;21(5):343-4.   2006年7月

Reducing the dose of antipsychotic agents ameliorates visual hypersensitivity attack: an ideal treatment option in terms of the adverse effect. 査読

Uchida H, Suzuki T, Yamazawa R, Tomita M, Nemoto T, Kimura Y, Watanabe K, Imasaka Y, Kashima H.

J Clin Psychopharmacol. 2006 Feb;26(1):50-5.   2006年2月

Combined treatment with sulpiride and paroxetine for accelerated response in patients with major depressive disorder. 査読

Uchida H, Takeuchi H, Suzuki T, Nomura K, Watanabe K, Kashima H.

J Clin Psychopharmacol. 2005 Dec;25(6):545-51.   2005年12月

Simplifying psychotropic medication regimen into a single night dosage and reducing the dose for patients with chronic schizophrenia. 査読

Suzuki T, Uchida H, Takeuchi H, Nomura K, Tanabe A, Watanabe K, Yagi G, Kashima H.

Psychopharmacology (Berl). 2005 Sep;181(3):566-75.   2005年9月

Two case reports of successful prevention of overdosing in borderline patients. 査読

Uchida H, Watanabe K, Suzuki T, Goto A, Kashima H.

Psychiatry. 2005;68(2):179-82.   2005年

Revising polypharmacy to a single antipsychotic regimen for patients with chronic schizophrenia. 査読

Suzuki T, Uchida H, Tanaka KF, Nomura K, Takano H, Tanabe A, Watanabe K, Yagi G, Kashima H.

Int J Neuropsychopharmacol. 2004 Jun;7(2):133-42.   2004年6月

A clinical case series of switching from antipsychotic polypharmacy to monotherapy with a second-generation agent on patients with chronic schizophrenia. 査読

Suzuki T, Uchida H, Watanabe K, Yagi G, Kashima H.

Prog Neuropsychopharmacol Biol Psychiatry. 2004 Mar;28(2):361-9.   2004年3月

Antipsychotic-induced paroxysmal perceptual alteration. 査読

Uchida H, Suzuki T, Watanabe K, Yagi G, Kashima H.

Am J Psychiatry. 2003 Dec;160(12):2243-4.   2003年12月

Reducing the dose of antipsychotic medications for those who had been treated with high-dose antipsychotic polypharmacy: an open study of dose reduction for chronic schizophrenia. 査読

Suzuki T, Uchida H, Tanaka KF, Tomita M, Tsunoda K, Nomura K, Takano H, Tanabe A, Watanabe K, Yagi G, Kashima H.

Int Clin Psychopharmacol. 2003 Nov;18(6):323-9.   2003年11月

Recurrent episodes of perceptual alteration in patients treated with antipsychotic agents. 査読

Uchida H, Suzuki T, Tanaka KF, Watanabe K, Yagi G, Kashima H.

J Clin Psychopharmacol. 2003 Oct;23(5):496-9.   2003年10月